- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.05. | AACE Pharma slammed with FDA warning letter for contract manufacturer's shortfalls | ||
| 29.05. | Pfizer again found to have discredited pharma industry with COVID-19 vaccine tweets | ||
| 29.05. | Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint | ||
| 29.05. | HHS axes Moderna's $590M pandemic bird flu vaccine contract, ending funding for late-phase trials | ||
| 28.05. | Alnylam choreographs new Givlaari promo in story of dancer's rare disease diagnosis | ||
| 28.05. | Scynexis says GSK on hook for $10M payment after phase 3 Brexafemme trial starts back up | ||
| 28.05. | Novartis emerged victorious in multi-month pursuit of Regulus and potential kidney blockbuster, filing shows | ||
| 28.05. | Big Pharma likely to endure Trump's tariff, pricing pressures, but threats to generics persist: S&P | ||
| 28.05. | InflaRx drops rare skin disease study for COVID med vilobelimab after futility signal | ||
| 27.05. | Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm | ||
| 27.05. | CDC pulls COVID vaccine recommendation for pregnant women, healthy children: RFK Jr. | ||
| 27.05. | AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide | ||
| 27.05. | Indivior nabs Sanofi, Endo alum as chief commercial officer | ||
| 27.05. | Olympic flame-out: Sanofi scorched for giving Paris 2024 tickets to UK patients | ||
| 27.05. | Seven top pharmas posted revenue declines in Q1. The common thread? All are US firms | ||
| 27.05. | FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset | ||
| 27.05. | Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs | ||
| 27.05. | Bio Usawa inks deal to deploy modular bio manufacturing units in Rwanda | ||
| 23.05. | AstraZeneca, Zero Prostate Cancer rev up early detection push at Memorial Day weekend NASCAR races | ||
| 23.05. | On the comeback trail, GSK's Blenrep scores thumbs up from Europe's CHMP | ||
| 23.05. | After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial | ||
| 22.05. | ASCO: Roche details Itovebi's survival benefit in certain breast cancers, further backing blockbuster plan | ||
| 22.05. | ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement | ||
| 22.05. | CDMO Samsung Biologics telegraphs spinoff of biosim unit | ||
| 22.05. | Novo offers Wegovy discount for new patients, launches new ad campaign as time runs out for compounders |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .